target

Juno Therapeutics

bidder

Celgene Corporation

£5,862m

60 dealmakers

target

Select Income Reit

bidder

Government Properties Income Trust

value n/a

17 dealmakers

target

Mars Drinks

bidder

Luigi Lavazza

£498m

13 dealmakers

target

Kite Pharma

bidder

Gilead Sciences

£9,302m

24 dealmakers

target

SIRIUSDECISIONS

bidder

Forrester Research

£190m

14 dealmakers

target

Webroot

bidder

Carbonite

£477m

19 dealmakers

target

Clementia Pharmaceuticals

bidder

IPSEN

£995m

41 dealmakers

target

Anicura Group

bidder

Mars Petcare

value n/a

11 dealmakers

target

Array Biopharma

bidder

Pfizer

£9,049m

51 dealmakers

target

Semma Therapeutics

bidder

Vertex Pharmaceuticals

£785m

26 dealmakers

target

Achillion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£732m

21 dealmakers

target

Carbonite

bidder

OPENTEXT

£1,110m

47 dealmakers

target

Arqule

bidder

Merck Kgaa

£2,054m

62 dealmakers

target

Forty Seven

bidder

Gilead Sciences

£3,821m

48 dealmakers

target

Stemline Therapeutics

bidder

Menarini Group

£541m

44 dealmakers

target

Cersci Therapeutics

bidder

Acadia Pharmaceuticals

£717m

20 dealmakers

target

Akcea Therapeutics

bidder

Ionis Pharmaceuticals

£334m

36 dealmakers

target

Pandion Therapeutics

bidder

Merck & Co

£1,308m

28 dealmakers

target

Wework Companies

bidder

Bow Capital

£6,532m

107 dealmakers

target

STRONGBRIDGE

bidder

Xeris Pharmaceuticals

£188m

53 dealmakers

target

Constellation Pharmaceuticals

bidder

Morphosys

£1,198m

58 dealmakers

target

Aspen Technology

bidder

Emerson Electric Co

£8,081m

49 dealmakers

target

DICERNA

bidder

Novo Nordisk

£2,452m

23 dealmakers

target

Antares Pharma

bidder

HALOZYME

£737m

59 dealmakers

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

target

Aerie Pharmaceuticals

bidder

Alcon

£650m

58 dealmakers

target

Incitec Pivot (waggaman Ammonia Production Facility)

bidder

Cf Industries Holdings

£1,373m

49 dealmakers

target

Triton International

bidder

Brookfield Infrastructure Partners

£10,708m

51 dealmakers

target

Bellus Health

bidder

Glaxosmithkline

£1,614m

17 dealmakers

target

Iveric Bio

bidder

Astellas Pharma

£4,693m

22 dealmakers

target

Cti Biopharma

bidder

Swedish Orphan Biovitrum (sobi)

£1,347m

76 dealmakers

target

Linnaeus Group

bidder

Mars Petcare

value n/a

9 dealmakers

target

Intercept Pharmaceuticals

bidder

Alfasigma

£649m

31 dealmakers

target

Point Biopharma

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

target

Mirati Therapeutics

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

target

ENGAGESMART

bidder

Vista Equity Partners

£3,288m

48 dealmakers

target

Ambrx

bidder

Johnson & Johnson

£1,493m

38 dealmakers

target

Alpine Immune Sciences

bidder

Vertex Pharmaceuticals

£3,867m

54 dealmakers